U.S. study was conducted during Delta variant dominance Two doses of the BNT162b2 vaccine proved to be 94% effective for preventing Covid-19 hospitalizations in teens and 98% effective for preventing Covid-related ICU admissions in a nationwide study involving adolescent patients conducted when the SARS-CoV-2 Delta variant was predominant in the United States. The real-world effectiveness